LATAM Adalimumab Market: Opportunities, Company Analysis and Forecast to 2023
The Latin America adalimumab market is dominated by a handful of companies, says a new report by Transparency Market Research (TMR). These companies are focused on capitalizing on untapped opportunities to display sustainable growth in the coming years. Furthermore, these companies have reduced prices of adalimumab to stay competitive in this market post the introduction of biologic drugs. This situation is expected to reflect in the form of higher sales of adalimumab in Latin America.
View full press release